NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Entegrion has received funding from NCBiotech -- and $88 million in contracts from various units in the U.S. Department of Defense (DOD) to help the RTP company keep building technologies that can save lives on battlefields by stopping blood loss and/or replacing lost blood components.

BioAgilytix Labs, a fast-growing Durham laboratory providing contract testing for pharmaceutical and biotechnology companies, has added two new high-efficiency testing devices to its arsenal.

G1 Therapeutics, a Chapel Hill company commercializing radiation-protection technology developed at the University of North Carolina at Chapel Hill, has raised $12.5 million in Series A funding.

At least two life science companies are among the 24 startups competing for NC IDEA grants worth as much as $50,000 apiece.
 

Just two years after breaking ground on a $70 million, 147,000-square-foot R&D expansion at its sprawling Research Triangle Park campus, Syngenta Biotechnology has announced another $94 million addition to the site.
 

Two North Carolina life-science collaborations are among five award winners in last week’s second annual Przirembel Prize competition at the InnoVenture Conference in Greenville, South Carolina.

  • Syngenta announces plans to begin construction on new biotechnology research facilities in Research Triangle Park
  • New facilities will include all-glass, climate-controlled greenhouses and precision growth chambers to study agronomic traits
  • Construction is scheduled to begin in summer 2011

scroll back to top of page